Original Articles
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin
R. C. T. Mori, S. M. Hirabara, A. E. Hirata, M. M. Okamoto U. F. Machado
Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation
R. R. Ortiz-Andrade, J. C. Sánchez-Salgado, G. Navarrete-Vázquez, S. P. Webster, M. Binnie, S. García-Jiménez, I. León-Rivera, P. Cigarroa-Vázquez, R. Villalobos-Molina S. Estrada-Soto
Research Letters
Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trial
S. W. Ma, I. F. F. Benzie,T. T. W. Chu, B. S. P. Fok, B. Tomlinson,L. A. H. Critchley,
Original Articles
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia*
W. A. Scherbaum, A. Schweizer, A. Mari, P. M. Nilsson, G. Lalanne, Y. Wang, B. E. Dunning J. E. Foley
Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?
I. Kusaka, S. Nagasaka, H. Horie S. Ishibashi
Effect of raisin consumption on oxidative stress and inflammation in obesity
J. W. Rankin, M. C. Andreae, C.-Y. Oliver Chen S. F. O’Keefe
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes*
J. Rosenstock, S. Sankoh J. F. List
Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial*
M. Davies, F. Lavalle-González, F. Storms R. Gomis (AT.LANTUS Study Group)
Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects*
This week's Diabetes Bulletin...
...
No comments:
Post a Comment